New York Community Bancorp Shareholders Approve 1-For-3 Reverse Stock Split-March 2024-www.financetom.com

New York Community Bancorp Shareholders Approve 1-For-3 Reverse Stock Split

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

New York Community Bancorp Shareholders Approve 1-For-3 Reverse Stock Split

Jun 5, 2024 11:21 AM

02:13 PM EDT, 06/05/2024 (MT Newswires) -- New York Community Bancorp ( NYCB/PU ) said Wednesday its shareholders have approved a 1-for-3 reverse stock split and a corresponding reduction in the total number of shares it is authorized to issue based on preliminary results of its annual meeting.

The stock was about 0.5% lower in recent trading.

Price: 3.12, Change: -0.01, Percent Change: -0.48

Previous page： SunPower to Report Q3’25 Results Oct. 21, 2025 Next page： LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition Plans

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

SunPower to Report Q3’25 Results Oct. 21, 2025

Oct 16, 2025

OREM, Utah, Oct. 16, 2025 (GLOBE NEWSWIRE) -- SunPower a solar technology, services, and installation company, will present its Q3’25 results via webcast on Tuesday, October 21 at 1:00pm ET. Interested parties may access the webcast by registering here or by visiting the Events page within the IR section of the company website: https://investors.sunpower.com/news-events/events. SunPower CEO T.J. Rodgers said, “It...

LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition Plans

Oct 16, 2025

Company underscores clinical execution and confirms advanced negotiations underway on acquisition of complementary oncology assets BOCA RATON, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ( LIXT ) , a clinical-stage pharmaceutical company advancing LB-100, a first-in-class inhibitor of protein phosphatase 2A (PP2A), today outlined its fourth-quarter 2025 priorities and provided an update on its strategic business...

GCL Executes MOU to Acquire Madeviral, Aiming to Accelerate Global Growth in Game Marketing and Publishing Support

Oct 16, 2025

SINGAPORE, Oct. 16, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd ( GCL ) , a leading provider of games and entertainment, today announced that it has entered into a non-binding Memorandum of Understanding (“MOU”) to acquire Madeviral, a Singapore-based full-service marketing agency specializing in gamer-focused marketing. Founded in 2016, Madeviral helps gaming brands create impactful game marketing strategies to...

SOLVE Acquires MBS Source to Expand Structured Products Coverage

Oct 16, 2025

Acquisition adds specialized mortgage- and asset-backed securities data and analytics to SOLVE’s multi-asset fixed income platform, enhancing capabilities for buy- and sell-side clients STAMFORD, Conn.--(BUSINESS WIRE)-- SOLVE, the leading provider of pre-trade data and predictive pricing for fixed income securities markets, today announced the acquisition of MBS Source, a provider of data and trading solutions for the mortgage- and...